# A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

> **NCT05028673** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lu AG06466 Capsule
- **DRUG:** Lu AG06466 Tablet
- **DRUG:** Antacid

## Key facts

- **NCT ID:** NCT05028673
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-23
- **Primary completion:** 2021-12-29
- **Final completion:** 2021-12-29
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05028673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05028673, "A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05028673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*